Imagion Biosystems Market Herald Interview
July 3, 2020
We recently announced plans to conduct our first in-human study for MagSense in Australia later this year. In this Market Herald interview, watch IBX CEO Bob
Category: News
Investor Webcast Presentation
June 23, 2020
Imagion Biosystems has released an investor webcast presentation announcement to the market. View the webcast presentation.
Imagion announces plan to undertake first clinical study in Australia
June 22, 2020
Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce its plans to conduct
Market Herald Interview
June 3, 2020
In May, Imagion signed a collaboration agreement with Siemens Healthineers to explore the utility of our MagSense nanoparticles as a contrast agent in MRI scanning.
Imagion Nanoparticle Manufacturing Update
May 26, 2020
Imagion Biosystems Limited is pleased to report that the first phase of manufacturing of the MagSense® HER2 nanoparticle formulation under Good Manufacturing Practice (GMP) conditions
Imagion Biosystems Establishes Collaboration with Siemens Healthineers
May 20, 2020
Imagion Biosystems Limited announces it has entered into a collaboration agreement with Siemens Healthcare Pty Ltd of Australia (Siemens Healthineers) to further explore the utility
Imagion Biosystems Nanoparticles Used in Viral Therapy Research
May 20, 2020
Imagion Biosystems Limited is pleased to share news of a recent publication, led by researchers at the Weill Cornell Medical College, which reports use of
Imagion Biosystems May 2020 Investor Newsletter
May 14, 2020
Imagion Biosystems Limited is pleased to provide investors with its May 2020 Investor Newsletter. The newsletter details recent key company developments and activities including: Message
Imagion Appoints New Non-Executive Director
May 11, 2020
Imagion Biosystems Limited today announced the appointment of Ms Dianne Angus to the Board of Directors. Ms Angus joined the Board as a Non-Executive Director
Annual Report to Shareholders
April 30, 2020
Imagion Biosystems has released its Annual Report to Shareholders for the year ended 31 December 2019. Read the Annual Report.